Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jan D Lünemann

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 30

Top Venues

Annals of neurology

Neurology(R) neuroimmunology & neuroinflammation

European journal of neurology

Annals of clinical and translational neurology

University of Münster

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Münster Oct 1o 2018

Germany

Professor :: Department of Neurology

Publications

Frauke Stascheit, Omar Chuquisana, Christian W Keller, Philip Alexander Ambrose, Sarah Hoffmann, Catharina C Gross, Sophie Lehnerer, Heinz Wiendl, Nick Willcox, Andreas Meisel, Jan D Lünemann
Complement Activation Profiles in Anti-AChR Positive Myasthenia Gravis. European journal of neurology (2023)
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, Neus Mongay-Ochoa, Andreu Vilaseca-Jolonch, Sara Llufriu, Yolanda Blanco, Harald Hegen, Klaus Berek, Francisco Perez-Miralles, Konrad Rejdak, Luisa M Villar, Enric Monreal, Roberto Álvarez-Lafuente, Onder K Soylu, Ahmed Abdelhak, Franziska Bachhuber, Hayrettin Tumani, Sergio Martínez-Yélamos, Antonio J Sánchez-López, Antonio García-Merino, Lucía Gutiérrez, Tamara Castillo Triviño, Jan Lycke, Igal Rosenstein, Roberto Furlan, Massimo Filippi, Nieves Téllez, Lluís Ramió-Torrentà, Jan D Lünemann, Heinz Wiendl, Sara Eichau, Micheal Khalil, Jens Kuhle, Xavier Montalban, Manuel Comabella Lopez
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Frauke Stascheit, Omar Chuquisana, Christian W Keller, Philip Alexander Ambrose, Sarah Hoffmann, Catharina C Gross, Sophie Lehnerer, Heinz Wiendl, Nick Willcox, Andreas Meisel, Jan D Lünemann
Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis. European journal of neurology (2023)
Louisa von Baumgarten, Hans J Stauss, Jan D Lünemann
Synthetic Cell-Based Immunotherapies for Neurologic Diseases. Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)
Sunny Malhotra, Luciana Midaglia, Omar Chuquisana, Nikolaos A Patsopoulos, Roser Ferrer, Marina Giralt, Nicolas Fissolo, Elia Gil-Varea, Juan Carlos Triviño, Jan D Lünemann, Xavier Montalban, Manuel Comabella Lopez
The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients. European journal of neurology (2023)
Louisa von Baumgarten, Hans J Stauss, Jan D Lünemann
Synthetic Cell-Based Immunotherapies for Neurologic Diseases. Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)
Louisa von Baumgarten, Hans J Stauss, Jan D Lünemann
Synthetic Cell-Based Immunotherapies for Neurologic Diseases. Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)
Omar Chuquisana, Christine Strippel, Anna M Tröscher, Tobias Baumgartner, Attila Rácz, Christian W Keller, Christian E Elger, Nico Melzer, Stjepana Kovac, Heinz Wiendl, Jan Bauer, Jan D Lünemann
Complement activation contributes to GAD antibody-associated encephalitis. Acta neuropathologica 144 (2) (2022)
Tobias Ruck, Falk Nimmerjahn, Heinz Wiendl, Jan D Lünemann
Next-generation antibody-based therapies in neurology. Brain : a journal of neurology 145 (4) (2022)
Jan D Lünemann
Getting specific: targeting Fc receptors in myasthenia gravis. Nature reviews. Neurology 17 (10) (2022)
Isabel Lutfullin, Maria Eveslage, Stefan Bittner, Gisela Antony, Martina Flaskamp, Felix Luessi, Salmen Anke, Barbara Gisevius, Luisa Klotz, Catharina Korsukewitz, Achim Berthele, Sergiu Groppa, Florian Then Bergh, Brigitte Wildemann, Antonios Bayas, Hayrettin Tumani, Sven G Meuth, Corinna Trebst, Uwe K Zettl, Friedemann Paul, Christoph Heesen, Tania Kuempfel, Ralf Gold, Bernhard Hemmer, Frauke Zipp, Heinz Wiendl, Jan D Lünemann, null null
Association of obesity with disease outcome in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2022)
Christian W Keller, Omar Chuquisana, Judith Derdelinckx, Catharina C Gross, Klaus Berger, James Robinson, Falk Nimmerjahn, Heinz Wiendl, Nick Willcox, Jan D Lünemann
Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis. Annals of neurology 92 (6) (2022)
Manuel Comabella Lopez, Mar Tintore, Augusto Sao Avilés, Pere Carbonell-Mirabent, Sunny Malhotra, Àlex Rovira, Nicolás Fissolo, Jan D Lünemann, Xavier Montalban
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2022)
Tilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, Rachel M Gittelman, Patrick Ostkamp, Florian Rubelt, Catarina Raposo, Björn Tackenberg, Marianne Riepenhausen, Claudia Janoschka, Christian Wuensch, Florence Bucciarelli, Andrea Flierl-Hecht, Eduardo Beltrán, Tania Kümpfel, Katja Anslinger, Catharina C Gross, Heidi Chapman, Ian Kaplan, David Brassat, Hartmut Wekerle, Martin Kerschensteiner, Luisa Klotz, Jan D Lünemann, Reinhard Hohlfeld, Roland S Liblau, Heinz Wiendl, Nicholas Schwab
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. The Journal of experimental medicine 219 (11) (2022)
Christian W Keller, Joseph A Lopez, Eva-Maria Wendel, Sudarshini Ramanathan, Catharina C Gross, Luisa Klotz, Markus Reindl, Russell C Dale, Heinz Wiendl, Kevin Rostásy, Fabienne Brilot, Jan D Lünemann
Reply to "Investigating the immunopathogenic mechanisms underlying MOGAD". Annals of neurology (2021)
Keertana Srimat Kandadai, Monika B Kotur, Nikolaos Dokalis, Irmgard Amrein, Christian W Keller, Christian Münz, David Wolfer, Marco Prinz, Jan D Lünemann
ATG5 in microglia does not contribute vitally to autoimmune neuroinflammation in mice. Autophagy 17 (11) (2021)
Christian W Keller, Joseph A Lopez, Eva-Maria Wendel, Sudarshini Ramanathan, Catharina C Gross, Luisa Klotz, Markus Reindl, Russell C Dale, Heinz Wiendl, Kevin Rostásy, Fabienne Brilot, Jan D Lünemann
Complement Activation Is a Prominent Feature of MOGAD. Annals of neurology 90 (6) (2021)
Jan D Lünemann, Manuel Comabella, Mari L Shinohara, Xavier Montalban, Manuel Comabella Lopez
Targeting Inflammasomes to Treat Neurological Diseases. Annals of neurology 90 (2) (2021)
Christian W Keller, Marc Pawlitzki, Heinz Wiendl, Jan D Lünemann
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. International journal of molecular sciences 22 (11) (2021)
Christian W Keller, Johanna Oechtering, Heinz Wiendl, Ludwig Kappos, Jens Kuhle, Jan D Lünemann
Impact of complement activation on clinical outcomes in multiple sclerosis. Annals of clinical and translational neurology 8 (4) (2021)
Jan D Lünemann, Judit Diaz-Diaz, Bruno Stankoff, Carolyn Young, Aksel Siva, Aaron Miller, Catherine Lubetzki, Heinz Wiendl, Celia Oreja-Guevara
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019). Multiple sclerosis (Houndmills, Basingstoke, England) 26 (7) (2020)
Michelle Schorer, Katharina Lambert, Nikolas Rakebrandt, Felix Rost, Kung-Chi Kao, Alexander Yermanos, Roman Spörri, Josua Oderbolz, Miro E Raeber, Christian W Keller, Jan D Lünemann, Gerhard Rogler, Onur Boyman, Annette Oxenius, Nicole Joller
Rapid expansion of Treg cells protects from collateral colitis following a viral trigger. Nature communications 11 (1) (2020)
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W Keller, Michael Prummer, Laurent Hoffmann, Janice K P Lam, Alan Kwok Shing Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D Lünemann, Michael Kammüller, Christian Münz
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS pathogens 16 (4) (2020)
Kayluz F Boligan, Johanna Oechtering, Christian W Keller, Benjamin Peschke, Robert Rieben, Nicolai Bovin, Ludwig Kappos, Richard D Cummings, Jens Kuhle, Stephan von Gunten, Jan D Lünemann
Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS. Neurology(R) neuroimmunology & neuroinflammation 7 (2) (2020)
Christian W Keller, Monika B Kotur, Sarah Mundt, Nikolaos Dokalis, Laure-Anne Ligeon, Ajay M Shah, Marco Prinz, Burkhard Becher, Christian Münz, Jan D Lünemann
CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation. Autophagy 17 (5) (2020)
Christian W Keller, Tobias Ruck, Donal McHugh, Steffen Pfeuffer, Catharina C Gross, Catharina Korsukewitz, Nico Melzer, Luisa Klotz, Sven G Meuth, Christian Münz, Falk Nimmerjahn, Heinz Wiendl, Jan D Lünemann
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis. Annals of clinical and translational neurology 6 (12) (2019)
Jan D Lünemann, Tobias Ruck, Paolo Antonio Muraro, Amit Bar-Or, Heinz Wiendl
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis. Nature reviews. Neurology 16 (1) (2019)
Christian W Keller, Jens Schmidt, Jan D Lünemann
Immune and myodegenerative pathomechanisms in inclusion body myositis. Annals of clinical and translational neurology 4 (6) (2017)
Christian W Keller, Christina Sina, Monika B Kotur, Giulia Ramelli, Sarah Mundt, Isaak Quast, Laure-Anne Ligeon, Patrick Weber, Burkhard Becher, Christian Münz, Jan D Lünemann
ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation. Proceedings of the National Academy of Sciences of the United States of America 114 (52) (2017)
Isaak Quast, Benjamin Peschke, Jan D Lünemann
Regulation of antibody effector functions through IgG Fc N-glycosylation. Cellular and molecular life sciences : CMLS 74 (5) (2016)

Jan D Lünemann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jan D Lünemann